Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Genitourinary 2CNS 2Other hematologic neoplasm 1Gynecologic 1Breast 1

Conditions

Urinary Bladder Neoplasms 1Urinary Bladder Diseases 1

Interventions

Docetaxel 409pembrolizumab 331Prednisone 290enzalutamide 285Gemcitabine 274Radiotherapy 270Magnetic Resonance Spectroscopy 269Nivolumab 253Abiraterone Acetate 218Cisplatin 212Leuprolide 195Radiosurgery 192Sunitinib 188Carboplatin 161Androgen Antagonists 156bicalutamide 152Specimen Handling 149Goserelin 149Ipilimumab 131Paclitaxel 126acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 122apalutamide 118Cyclophosphamide 117Bevacizumab 116Sorafenib 114Everolimus 111abiraterone 108cabozantinib 105atezolizumab 105Biopsy 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Microscopy × Genitourinary × Clear all
NCT04914442 2021-06-04

Eosinophilic Cystitis Mimicking Urothelial Neoplasia

Al-Azhar University

Completed
22 enrolled
Genitourinary

Urinary Bladder Diseases

NCT01118351 2019-05-01

Sunitinib Malate in Treating Patients With Recurrent Transitional Cell Bladder Cancer

Case Comprehensive Cancer Center

Phase 2 Terminated
19 enrolled 11 charts
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡